Neurobehavioral Medicine Group is a clinical research site located in Bloomfield Hills, Michigan, United States 48302.
Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.
Neurobehavioral Medicine Group has participated in 22 clinical trials with 5 currently active.
Therapeutic areas: Insomnia, Attention Deficit Hyperactivity Disorder, Autism Spectrum Disorder.
Sponsors: Sumitomo Pharma America, Inc., MapLight Therapeutics, Emalex Biosciences Inc..
Trust Score: 82/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Neurobehavioral Medicine Group has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Neurobehavioral Medicine Group has 22 clinical trials on record, with 5 currently active. Their work covers Insomnia, Attention Deficit Hyperactivity Disorder, Autism Spectrum Disorder.
Yes — Neurobehavioral Medicine Group holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.